RBC Bioscience

RBC Bioscience Acquisitions (Net)

The Acquisitions (Net) of RBC Bioscience (6848.TWO) as of Oct 17, 2026 is -7.83 M TWD. In the previous year, Acquisitions (Net) was 5.81 M TWD — a change of -234.80% (lower).

Acquisitions (Net)

-7.83 MTWD

YoY

-234.80%

Last updated:

Acquisitions (Net) of RBC Bioscience is 2024 -7.83 M TWD. Acquisitions (Net) of RBC Bioscience was 2023 5.81 M TWD. It decreases by -234.80% lower compared to the previous year.

The RBC Bioscience Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2018
1,000.00 TWD
Jan 1, 2019
-206,000.00 TWD
Jan 1, 2020
-1.09 M TWD
Jan 1, 2021
24.45 M TWD
Jan 1, 2022
18.55 M TWD
Jan 1, 2023
5.81 M TWD
Jan 1, 2024
-7.83 M TWD
The RBC Bioscience Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-7.83 MTWD-234.80%
5.81 MTWD-68.67%
18.55 MTWD-24.13%
24.45 MTWD-2,334.73%
-1.09 MTWD+431.07%
-206,000.00TWD-20,700.00%
1,000.00TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp, based in Taipei, Taiwan, operates in the Health Care sector within the Life Sciences Tools & Services industry. The company manufactures reagents and devices for life science and molecular diagnosis, including instruments with ultraviolet sterilization systems and disposable reagent strips for nucleic acid extraction. Its products, featuring cellulose-embedded magnetic beads, purify DNA and RNA from various sources for diagnostic and forensic applications. Listed on 25 October 2021, RBC Bioscience serves markets requiring advanced molecular analysis tools. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Acquisitions (Net) of RBC Bioscience is -7.83 M TWD in 2024.

Acquisitions (Net) of RBC Bioscience changed from 5.81 M TWD to -7.83 M TWD, representing a -234.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — RBC Bioscience

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — RBC Bioscience